In contrast, CAPS expression was markedly reduced in high-grade tumors (G2-G3), serous carcinoma, advanced-stage disease (stage III-IV), and tumors with deep myometrial invasion (all P < 0.05). The gene discussed is CAPS; the disease is serous adenocarcinoma.